Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 2151 3683 3686 3715
This examiner grants 46% of resolved cases
Devin C. Hein is a patent examiner in Art Unit 2151, which falls under Tech Center 3700. He has a substantial portfolio of 308 resolved cases. His allowance rate is 46.1 percent, suggesting a challenging prosecution environment where fewer than half of the applications are granted. This 46.1 percent rate indicates that applicants must be prepared for rigorous scrutiny and potential multiple rounds of rejection. The 308 resolved cases provide a strong foundation for analyzing his examination tendencies.
The data highlights a significant opportunity for applicants through the use of interviews. The interview lift is 29.5 percent, which is a substantial increase over the 46.1 percent baseline allowance rate. This suggests that direct engagement with the examiner is a highly effective strategy for resolving issues and moving applications toward allowance. Given the 29.5 percent lift, practitioners should strongly consider scheduling an interview early in the prosecution process to address the examiner's concerns and clarify the technical aspects of the invention in Art Unit 2151.
The median days to allowance for his cases is 1273. This is a relatively long timeline for applications in Tech Center 3700. Applicants should factor this 1273-day median pendency into their long-term intellectual property planning. The combination of a 46.1 percent allowance rate and a 1273-day median pendency underscores the necessity of using every available tool, particularly the 29.5 percent interview lift, to navigate the process efficiently.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18611519 | METHODS AND USER INTERFACES FOR ACCESSING AND MANAGING WORKOUT CONTENT AND INFORMATION | Final Rejection | Apple Inc. |
| 19357681 | ARCHITECTURE FOR INTEROPERABLE UROLOGY OPERATING ROOM | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19068356 | SYSTEMS AND METHODS FOR COORDINATION OF MEDICATION ADJUSTMENT AND NEUROMODULATION THERAPY | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18833082 | GUIDANCE ASSISTANCE APPARATUS, GUIDANCE ASSISTANCE METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18713777 | STRESS ESTIMATION METHOD | Final Rejection | NEC Corporation |
| 18954228 | CONFLICTING DATA STREAMS IN MULTI-SYSTEM INTERACTION | Non-Final OA | Cilag GmbH International |
| 19327264 | COMPUTER-IMPLEMENTED WORKFLOW GENERATION METHOD, INFORMATION PROCESSING APPARATUS, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM | Non-Final OA | Fujitsu Limited |
| 18713758 | SYSTEMS AND METHODS FOR IDENTIFYING SUBJECTS FOR CLINICAL TRIALS | Final Rejection | Eli Lilly and Company |
| 19080665 | System for Medicinal Supply Monitoring and Management for Pooled Medicinal Product Across Studies | Non-Final OA | Merck Sharp & Dohme LLC |
| 19012201 | FAIRNESS-AWARE DOMAIN GENERALIZATION FOR MEDICAL DECISION MAKING | Final Rejection | NEC Laboratories America, Inc. |
| 19268294 | PATIENT MANAGEMENT BASED ON SENSED INPUTS | Final Rejection | Hill-Rom Services, Inc. |
| 18150237 | DIGITAL ANTIMICROBIAL STEWARDSHIP SYSTEM | Final Rejection | Roche Molecular Systems, Inc. |
| 18086375 | TAGGING PATIENT REFERRALS | Non-Final OA | Matrixcare, Inc. |
| 19104555 | RADIATION TRACKING AND MONITORING SYSTEM | Non-Final OA | Medtronic Vascular, Inc. |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | Final Rejection | ASTRAZENECA AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy